Remi Meds review

Remi Meds prices sermorelin against the actual weekly volume rather than a single vague "from" price: $249 a month for 3 ml a week, $349 for 9 ml, with NAD⁺ at $349 for 10 ml a week. Stating the volume beside the price is what makes a real comparison possible, and its FAQ goes further by naming Strive Pharmacy with a full address and Beluga Health as the prescribing network. The operator side is where it wobbles — no named physician, no state list behind a bare nationwide claim, three different phone numbers across the site and a contact email at a different brand entirely.

Remi Meds is a direct-to-consumer telehealth platform with a compact menu organized by outcome: Weight Loss (personalized GLP-1 and GLP-1/GIP with B12), Energy + Mood (NAD⁺ injections and NAD⁺ troches), Cardio + Strength (sermorelin injections and sermorelin troches) and Antioxidant (glutathione injections and glutathione troches). It describes itself as a patient-management platform partnering with independent licensed physician networks — not a pharmacy and not a medical provider — and states that payment does not guarantee a prescription will be written or dispensed. It publishes a mailing address at 920 E. Dixie Ave, Suite A, Leesburg, Florida.

Questionnaire, then a provider review stated as inside 24 hours, then shipment from a partner pharmacy on eligibility, with regular check-ins afterwards. Some states require a live video consultation or secure chat to complete the visit, and identity is checked with a photo ID and selfie. Two disclosures stand out for the better and one set of details for the worse. Better: the FAQ names Strive Pharmacy in Gilbert, Arizona with a street address, phone number and email, and names Beluga Health with its website as the prescribing network — most competitors will not name either. Worse: the site publishes three different phone numbers across its header, footer and contact block, and the contact panel carries an email address belonging to Rekindle Rx, a different brand, which suggests shared back-office infrastructure the site does not explain. No medical director, founder or individual physician appears on any public page, and the state position is a bare "we offer nationwide service" with an invitation to contact support if you are unsure — which is not the same as publishing where you are licensed. The FAQ's own line on accreditation is oddly soft, saying it encourages the use of LegitScript or NABP-accredited facilities rather than stating that its partner is one. Billing is described as charged when the medication ships. Note also that its clinical partner, Beluga Health, has been named in reporting as the network behind a number of FDA-warned GLP-1 companies; Remi Meds itself has not been the subject of an FDA warning letter, and the association is worth knowing rather than treating as a verdict.

Unusually specific, and that is the reason to look. Sermorelin is $249 a month for 3 ml a week as a starting dose and $349 a month for 9 ml a week. NAD⁺ injections are $349 a month at 10 ml a week, described as a 30-day supply shipped every 30 days. The sublingual troches are priced too: a sermorelin mini troche at $249 as a starting dose, NAD⁺ troches at $349 for thirty 200 mg troches on the same 30-day cadence, and glutathione troches at $209. Glutathione is where the discipline slips: the subcutaneous injection is listed at $219 with no billing period stated anywhere on the page, and the sermorelin and glutathione troche listings state none either, so it is not clear whether those figures are a month, a vial or a course — ask before ordering, and do not assume monthly. Dosage is stated as set by the licensed provider on medical judgment, so the tier you land on is not yours to choose. On the weight-loss side, GLP-1 runs $249 to $369 a month by dose tier and GLP-1/GIP with B12 runs $349 to $639, fully laid out rather than hidden behind an "as low as" — but those are GLP-1 numbers and are not a peptide price. Shipping is stated as free in one to four days if prescribed, and all prescription sales are final once the order ships.

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. Remi Meds states it is not a pharmacy and does not provide medical services directly, names Strive Pharmacy as its partner in the FAQ, and carries a clear non-affiliation disclaimer for the branded GLP-1 trademarks — but compounded sterile preparations are not reviewed by the FDA for purity and potency the way approved drugs are, whoever prepares them. On the evidence, the three wellness molecules diverge sharply. Sermorelin is a growth-hormone-releasing hormone analog that stimulates the pituitary to release your own growth hormone rather than supplying it exogenously, which preserves the feedback loop injected HGH bypasses; the mechanism is real and well described, and the long-term human outcome data behind the body-composition, sleep and recovery claims stays thin. Its own product page's claim that sermorelin has been "clinically proven to increase HGH levels" is fair as far as it goes — raising GH and IGF-1 is measurable — but a raised hormone level is not the same as a demonstrated clinical outcome, and the page's leap to fat breakdown, muscle growth and bone strengthening runs ahead of the human evidence. Injected and sublingual NAD⁺ have no controlled human outcome trials; oral NR and NMN are the studied forms and what they show is a raised blood NAD⁺ level. Injectable glutathione has essentially no controlled human outcome data behind the brightening, detoxification and immune claims made for it. Individual results vary.